VANCOUVER, British Columbia--(BUSINESS WIRE)--Life Sciences British Columbia (LSBC) announces the companies presenting at the first annual Invest in the West presented by Amplitude Ventures on March 10, 2022. This virtual conference showcases a broad range of investor-ready life sciences companies from the Western Canada healthcare innovation ecosystem. The companies, who are seeking investors and strategic partners, have been selected following adjudication by an expert panel assessing investor readiness. Pitching sessions include diagnostics, digital health, therapeutics, medical devices, and medical technology, and an early look at graduating small and mid-size enterprises (SMEs) from our Investor Readiness Program 2022.
During the event, entrepreneurs will pitch their companies to secure funding from a wide range of investor stakeholders including , venture capitalists, corporate venture leaders and funding foundations. Held in collaboration with BioAlberta and Bioscience Association Manitoba, these sessions will showcase opportunities from the life sciences sector across Western Canada. Attendees will also have the opportunity to network through the virtual platform and set up Business to Business meetings
Invest in the West presented by Amplitude Ventures, is one of Life Sciences BC ’s investment- and innovation-focused signature events. Throughout the year, LSBC programs and initiatives raise the life sciences profile at home and abroad to encourage investment and global partnering opportunities.
Presenting Companies
- 4M BioTech
- Apricell Biotechnology Inc.
- ARTMS Inc
- Axolotl Biosciences
- Bold Therapeutics Inc.
- Cubresa
- Entos Pharmaceuticals
- Eyam Vaccines and Immunotherapeutics Ltd
- Healthcare Systems R & A Inc.
- HTuO Biosciences
- L9 BioScience Inc.
- Lumeca Health Inc.
- Mesintel Therapeutics
- Nanostics Inc
- Neuraura Biotech Inc.
- ORX Surgical
- Primary Peptides Inc.
- Rostrum Medical Innovations
- Total Flow Medical
- OncoDrex
- VoxCell BioInnovation
For more details and event registration, please visit: https://lifesciencesbc.ca/event/invest-in-the-west-presented-by-amplitude-ventures/
About Life Sciences BC
Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and promotion of our world-class science and industry.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, Life Sciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.
About the BC life sciences sector
BC is home to the fastest growing life sciences sector in Canada and our reputation is global. Vancouver was recently named the 2021 top life sciences start up ecosystem in Canada. Startup Genome ranked Vancouver 21 out of 280 global ecosystems, listing it as the only Canadian city in the top 25.
BC life sciences exceed Canada’s life sciences GDP growth (2018 data) and employ more than 18,000 employees (2020 data) at above-average salaries. During 2020, BC biotech companies more than doubled revenue from the top four deals compared to 2019.
